Novo Nordisk, the manufacturer of Wegovy, offers a 7.2 mg dose to patients who do not benefit enough from the previous maximum dose of 2.4 mg
A review of pivotal clinical trials for semaglutide (STEP, SUSTAIN), dulaglutide (REWIND), liraglutide (LEADER), and tirzepatide (SURPASS, SURMOUNT) does not identify muscle cramps as occurring at significantly higher rates compared to placebo groups
Portion sizes naturally decrease without conscious restriction
IV treatment is usually the most effective because it provides glutathione directly and quickly to the body
For panic disorder, many people notice fewer and less intense panic attacks within 612 weeks
Do not gamble with timing